{
  "disease_name": "Acute intermittent porphyria",
  "orpha_code": "79276",
  "drugs": [
    {
      "name": "Adeno-associated viral vector containing porphobilinogen deaminase gene",
      "substance_url": "/en/drug/substance/178058?name=79276&mode=orpha&region=&status=all",
      "substance_id": "178058",
      "regulatory_url": "/en/drug/regulatory/189191?name=79276&mode=orpha&region=",
      "regulatory_id": "189191",
      "orpha_substance_code": "ORPHA:79276",
      "details": [
        "Adeno-associated viral vector containing porphobilinogen deaminase gene(Medicinal product                        - 29/04/2009)Disease(s) concernedORPHA:79276 Acute intermittent porphyria",
        "Adeno-associated viral vector containing porphobilinogen deaminase gene(Medicinal product                        - 29/04/2009)",
        "(Medicinal product                        - 29/04/2009)",
        "Disease(s) concernedORPHA:79276 Acute intermittent porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/178058?name=79276&mode=orpha&region=&status=all",
          "text": "Adeno-associated viral vector containing porphobilinogen deaminase gene",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79276",
          "text": "ORPHA:79276 Acute intermittent porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/189191?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Recombinant human porphobilinogen deaminase",
      "substance_url": "/en/drug/substance/133637?name=79276&mode=orpha&region=&status=all",
      "substance_id": "133637",
      "regulatory_url": "/en/drug/regulatory/133784?name=79276&mode=orpha&region=",
      "regulatory_id": "133784",
      "orpha_substance_code": "ORPHA:79276",
      "details": [
        "Recombinant human porphobilinogen deaminase(Medicinal product                        - 12/06/2002)Disease(s) concernedORPHA:79276 Acute intermittent porphyria",
        "Recombinant human porphobilinogen deaminase(Medicinal product                        - 12/06/2002)",
        "(Medicinal product                        - 12/06/2002)",
        "Disease(s) concernedORPHA:79276 Acute intermittent porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/133637?name=79276&mode=orpha&region=&status=all",
          "text": "Recombinant human porphobilinogen deaminase",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/79276",
          "text": "ORPHA:79276 Acute intermittent porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/133784?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "GIVLAARI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/573501?name=79276&mode=orpha&region=",
      "regulatory_id": "573501",
      "orpha_substance_code": "ORPHA:95157",
      "details": [
        "GIVLAARI(Tradename                        - 02/03/2020)Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "GIVLAARI(Tradename                        - 02/03/2020)",
        "(Tradename                        - 02/03/2020)",
        "Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/573500?name=79276&mode=orpha&region=&status=all",
          "text": "GIVLAARI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/95157",
          "text": "ORPHA:95157 Acute hepatic porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/573501?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Givosiran",
      "substance_url": "/en/drug/substance/480914?name=79276&mode=orpha&region=&status=all",
      "substance_id": "480914",
      "regulatory_url": "/en/drug/regulatory/480915?name=79276&mode=orpha&region=",
      "regulatory_id": "480915",
      "orpha_substance_code": "ORPHA:95157",
      "details": [
        "Givosiran(Medicinal product                        - 29/08/2016)Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "Givosiran(Medicinal product                        - 29/08/2016)",
        "(Medicinal product                        - 29/08/2016)",
        "Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480914?name=79276&mode=orpha&region=&status=all",
          "text": "Givosiran",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/95157",
          "text": "ORPHA:95157 Acute hepatic porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/480915?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "GIVLAARI",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/574106?name=79276&mode=orpha&region=",
      "regulatory_id": "574106",
      "orpha_substance_code": "ORPHA:95157",
      "details": [
        "GIVLAARI(Tradename                        - 20/11/2019)Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "GIVLAARI(Tradename                        - 20/11/2019)",
        "(Tradename                        - 20/11/2019)",
        "Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/573500?name=79276&mode=orpha&region=&status=all",
          "text": "GIVLAARI",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/95157",
          "text": "ORPHA:95157 Acute hepatic porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/574106?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "PANHEMATIN",
      "substance_url": null,
      "substance_id": null,
      "regulatory_url": "/en/drug/regulatory/131060?name=79276&mode=orpha&region=",
      "regulatory_id": "131060",
      "orpha_substance_code": "ORPHA:738",
      "details": [
        "PANHEMATIN(Tradename                        - 20/07/1990)Disease(s) concernedORPHA:738 Porphyria",
        "PANHEMATIN(Tradename                        - 20/07/1990)",
        "(Tradename                        - 20/07/1990)",
        "Disease(s) concernedORPHA:738 Porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/trade_name/24989?name=79276&mode=orpha&region=&status=all",
          "text": "PANHEMATIN",
          "type": "trade_name_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/738",
          "text": "ORPHA:738 Porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131060?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Tradename",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Burixafor",
      "substance_url": "/en/drug/substance/689505?name=79276&mode=orpha&region=&status=all",
      "substance_id": "689505",
      "regulatory_url": "/en/drug/regulatory/689915?name=79276&mode=orpha&region=",
      "regulatory_id": "689915",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Burixafor(Medicinal product                        - 22/10/2024)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Burixafor(Medicinal product                        - 22/10/2024)",
        "(Medicinal product                        - 22/10/2024)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/689505?name=79276&mode=orpha&region=&status=all",
          "text": "Burixafor",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/689915?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Givosiran",
      "substance_url": "/en/drug/substance/480914?name=79276&mode=orpha&region=&status=all",
      "substance_id": "480914",
      "regulatory_url": "/en/drug/regulatory/574107?name=79276&mode=orpha&region=",
      "regulatory_id": "574107",
      "orpha_substance_code": "ORPHA:95157",
      "details": [
        "Givosiran(Medicinal product                        - 29/08/2016)Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "Givosiran(Medicinal product                        - 29/08/2016)",
        "(Medicinal product                        - 29/08/2016)",
        "Disease(s) concernedORPHA:95157 Acute hepatic porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/480914?name=79276&mode=orpha&region=&status=all",
          "text": "Givosiran",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/95157",
          "text": "ORPHA:95157 Acute hepatic porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/574107?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    },
    {
      "name": "Treosulfan",
      "substance_url": "/en/drug/substance/90799?name=79276&mode=orpha&region=&status=all",
      "substance_id": "90799",
      "regulatory_url": "/en/drug/regulatory/136690?name=79276&mode=orpha&region=",
      "regulatory_id": "136690",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "Treosulfan(Medicinal product                        - 08/04/2015)Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "Treosulfan(Medicinal product                        - 08/04/2015)",
        "(Medicinal product                        - 08/04/2015)",
        "Disease(s) concernedORPHA:213500 Rare ovarian cancerORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/90799?name=79276&mode=orpha&region=&status=all",
          "text": "Treosulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/213500",
          "text": "ORPHA:213500 Rare ovarian cancer",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/136690?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "busulfan",
      "substance_url": "/en/drug/substance/46335?name=79276&mode=orpha&region=&status=all",
      "substance_id": "46335",
      "regulatory_url": "/en/drug/regulatory/131973?name=79276&mode=orpha&region=",
      "regulatory_id": "131973",
      "orpha_substance_code": "ORPHA:565779",
      "details": [
        "busulfan(Medicinal product                        - 21/04/1994)Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "busulfan(Medicinal product                        - 21/04/1994)",
        "(Medicinal product                        - 21/04/1994)",
        "Disease(s) concernedORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/46335?name=79276&mode=orpha&region=&status=all",
          "text": "busulfan",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/565779",
          "text": "ORPHA:565779 Rare disorder potentially indicated for transplant or complication after transplantation",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131973?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": "potentially indicated for transplant or complication after transplantation\n                                \n\n\n\n\n\n\n            More details on the regulatory status",
      "regions": [
        "US"
      ]
    },
    {
      "name": "Hemin",
      "substance_url": "/en/drug/substance/24990?name=79276&mode=orpha&region=&status=all",
      "substance_id": "24990",
      "regulatory_url": "/en/drug/regulatory/131924?name=79276&mode=orpha&region=",
      "regulatory_id": "131924",
      "orpha_substance_code": "ORPHA:738",
      "details": [
        "Hemin(Medicinal product                        - 16/03/1984)Disease(s) concernedORPHA:738 Porphyria",
        "Hemin(Medicinal product                        - 16/03/1984)",
        "(Medicinal product                        - 16/03/1984)",
        "Disease(s) concernedORPHA:738 Porphyria",
        "More details on the regulatory status"
      ],
      "links": [
        {
          "url": "https://www.orpha.net/en/drug/substance/24990?name=79276&mode=orpha&region=&status=all",
          "text": "Hemin",
          "type": "substance_details"
        },
        {
          "url": "https://www.orpha.net/en/disease/detail/738",
          "text": "ORPHA:738 Porphyria",
          "type": "disease_details"
        },
        {
          "url": "https://www.orpha.net/en/drug/regulatory/131924?name=79276&mode=orpha&region=",
          "text": "More details on the regulatory status",
          "type": "regulatory_status"
        }
      ],
      "status": "Medicinal product",
      "manufacturer": null,
      "indication": null,
      "regions": [
        "US"
      ]
    }
  ],
  "processing_timestamp": "2025-07-07T06:04:34.128331",
  "run_number": 1,
  "total_drugs_found": 11,
  "search_url": "https://www.orpha.net/en/drug?diseaseName=Acute+intermittent+porphyria&orphaCode=79276&name=79276&region=&mode=orpha&status=all",
  "search_params": {
    "diseaseName": "Acute intermittent porphyria",
    "orphaCode": "79276",
    "name": "79276",
    "region": "",
    "mode": "orpha",
    "status": "all"
  }
}